The α-synuclein (αSyn) seed amplification assay (SAA) identifies αSyn aggregates as a sign of Lewy body pathology in patient-derived biomaterials, aiding the diagnosis of dementia syndromes and PD [30]. This evidence concerns the gene SNCA and Parkinson disease.